FinTechFunding

Race Oncology: Reports $1.8m in cash outflows

Race Oncology Reports $1.8m in cash outflows

  • Race Oncology (RAC) reports $1.8 million in cash outflows for the quarter, an increase from the $931,000 in outflows recorded in the previous quarter
  • The company spent $890,000 during the period for research and development
  • RAC’s focus is Zantrene, a small molecule anti-cancer drug in which the company announced numerous achievements for over the quarter
  • At the end of the period, the company had $37.1 million in cash and cash equivalents
  • Shares closed 2.81 per cent higher today at $2.93 each
Previous article
Tink: Launches “Income Check” in the UK to simplify income verification
Next article
White Cliff Minerals: Completes Cracker Jack drilling
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

IG Group Considers Switching Listing from London to New York

The financial services firm explores a potential move to enhance visibility. Highlights: IG Group is weighing a move from...
FinTech

Huawei and Yowpay Launch Open Banking Smartwatch POS App

Innovative app combines open banking with smartwatch technology for payments. Highlights: Huawei partners with Yowpay to introduce a smartwatch...
FinTech

UK Banks Reject Opportunity to Lift £100 Contactless Limit

Major UK banks choose not to increase contactless payment thresholds. Highlights: UK banks will not raise the £100 contactless...
FinTech

Crypto.com Cuts 12% of Workforce Amid AI Shift

The company streamlines operations in response to evolving market dynamics. Highlights: Crypto.com reduces workforce by 12%Focus shifts to AI...